MX9704024A - Composicion y metodo para la prevencion y el tratamiento de infeccion con vih-1. - Google Patents
Composicion y metodo para la prevencion y el tratamiento de infeccion con vih-1.Info
- Publication number
- MX9704024A MX9704024A MX9704024A MX9704024A MX9704024A MX 9704024 A MX9704024 A MX 9704024A MX 9704024 A MX9704024 A MX 9704024A MX 9704024 A MX9704024 A MX 9704024A MX 9704024 A MX9704024 A MX 9704024A
- Authority
- MX
- Mexico
- Prior art keywords
- hiv
- reverse transcriptase
- infection
- prevention
- treatment
- Prior art date
Links
- 101900297506 Human immunodeficiency virus type 1 group M subtype B Reverse transcriptase/ribonuclease H Proteins 0.000 title abstract 3
- 239000003419 rna directed dna polymerase inhibitor Substances 0.000 title abstract 3
- 208000031886 HIV Infections Diseases 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- -1 anilide compound Chemical class 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000000446 sulfanediyl group Chemical group *S* 0.000 abstract 2
- 108010078851 HIV Reverse Transcriptase Proteins 0.000 abstract 1
- 241000713772 Human immunodeficiency virus 1 Species 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Una composicion y método para la prevencion o el tratamiento de infeccion por VIH-1, la cual comprende un compuesto de carb(ox/tio)anilida heterociclílica inhibidor de transcriptasa inversa de VIH-1, un segundo compuesto inhibidor de transcriptasa inversa de VIH-1 que no selecciona para la misma cepa o cepas mutantes de VIH-1 seleccionadas por el compuesto de carb(ox/tio)anilida heterociclílica, y opcionalmente un tercer compuesto inhibidor de transcriptasa inversa de VIH.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US346721 | 1994-11-30 | ||
| US08/346,721 US5968910A (en) | 1994-11-30 | 1994-11-30 | Compositions containing two or three inhibitors of different HIV reverse transcriptases |
| PCT/EP1995/004704 WO1996016675A2 (en) | 1994-11-30 | 1995-11-29 | Composition for prevention and treatment of hiv-1 infection comprising at least two different hiv-1 reverse transcriptase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MXPA97004024A MXPA97004024A (es) | 1998-02-01 |
| MX9704024A true MX9704024A (es) | 1998-02-28 |
Family
ID=23360750
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9704024A MX9704024A (es) | 1994-11-30 | 1995-11-29 | Composicion y metodo para la prevencion y el tratamiento de infeccion con vih-1. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5968910A (es) |
| EP (1) | EP0794793B1 (es) |
| JP (1) | JP3655636B2 (es) |
| KR (1) | KR100403545B1 (es) |
| CN (1) | CN1104909C (es) |
| AU (1) | AU717025B2 (es) |
| BR (1) | BR9509925A (es) |
| CA (1) | CA2204652C (es) |
| DE (1) | DE69535366T2 (es) |
| HU (1) | HU223548B1 (es) |
| IL (1) | IL115944A (es) |
| MX (1) | MX9704024A (es) |
| NZ (1) | NZ297006A (es) |
| RU (1) | RU2227750C2 (es) |
| WO (1) | WO1996016675A2 (es) |
| ZA (1) | ZA9510108B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5696151A (en) * | 1995-11-30 | 1997-12-09 | Uniroyal Chemical Company, Inc. | Compounds useful for the inhibition of the replication of HIV-1 and HIV-1 mutants |
| JP2001512830A (ja) * | 1997-08-08 | 2001-08-28 | ニューバイオティックス インコーポレイテッド | 生物療法耐性および化学療法耐性を克服するための方法および組成物 |
| US7462605B2 (en) * | 1998-01-23 | 2008-12-09 | Celmed Oncology (Usa), Inc. | Phosphoramidate compounds and methods of use |
| ES2172303T3 (es) | 1998-01-23 | 2002-09-16 | Newbiotics Inc | Agentes terapeuticos obtenidos por catalisis enzimatica. |
| US6683061B1 (en) | 1999-07-22 | 2004-01-27 | Newbiotics, Inc. | Enzyme catalyzed therapeutic activation |
| WO2001007088A2 (en) | 1999-07-22 | 2001-02-01 | Newbiotics, Inc. | Methods for treating therapy-resistant tumors |
| WO2001021160A2 (en) * | 1999-09-23 | 2001-03-29 | Axxima Pharmaceuticals Aktiengesellschaft | Carboxymide and aniline derivatives as selective inhibitors of pathogens |
| UA74826C2 (en) * | 2000-05-17 | 2006-02-15 | Ortho Mcneil Pharm Inc | ?-carboline derivatives as phosphodiesterase inhibitors |
| CN101108178B (zh) * | 2006-07-20 | 2010-09-15 | 复旦大学 | 一种亲环素a抑制剂在制备抗艾滋病药物中的应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5268389A (en) * | 1989-10-16 | 1993-12-07 | Uniroyal Chemical Company, Inc. | Thiocarboxylate ester compounds compositions containing the same |
| IL99843A0 (en) * | 1990-11-01 | 1992-08-18 | Merck & Co Inc | Synergistic combination of hiv reverse transcriptase inhibitors |
| EP0530407B1 (en) * | 1991-09-04 | 1996-06-05 | Stichting REGA V.Z.W. | Substituted, nucleoside derivatives, methods for their preparation and pharmaceutical compositions containing them |
-
1994
- 1994-11-30 US US08/346,721 patent/US5968910A/en not_active Expired - Lifetime
-
1995
- 1995-11-09 IL IL11594495A patent/IL115944A/en not_active IP Right Cessation
- 1995-11-28 ZA ZA9510108A patent/ZA9510108B/xx unknown
- 1995-11-29 MX MX9704024A patent/MX9704024A/es unknown
- 1995-11-29 DE DE69535366T patent/DE69535366T2/de not_active Expired - Lifetime
- 1995-11-29 NZ NZ297006A patent/NZ297006A/en not_active IP Right Cessation
- 1995-11-29 RU RU97110670/15A patent/RU2227750C2/ru active
- 1995-11-29 WO PCT/EP1995/004704 patent/WO1996016675A2/en active IP Right Grant
- 1995-11-29 JP JP51818896A patent/JP3655636B2/ja not_active Expired - Fee Related
- 1995-11-29 KR KR1019970703579A patent/KR100403545B1/ko not_active IP Right Cessation
- 1995-11-29 HU HU9800354A patent/HU223548B1/hu active IP Right Grant
- 1995-11-29 AU AU41769/96A patent/AU717025B2/en not_active Expired
- 1995-11-29 EP EP95940258A patent/EP0794793B1/en not_active Expired - Lifetime
- 1995-11-29 CA CA002204652A patent/CA2204652C/en not_active Expired - Lifetime
- 1995-11-29 BR BR9509925A patent/BR9509925A/pt not_active IP Right Cessation
- 1995-11-29 CN CN95196540A patent/CN1104909C/zh not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| RU2227750C2 (ru) | 2004-04-27 |
| JP3655636B2 (ja) | 2005-06-02 |
| CA2204652C (en) | 2009-04-07 |
| WO1996016675A2 (en) | 1996-06-06 |
| EP0794793B1 (en) | 2007-01-10 |
| AU4176996A (en) | 1996-06-19 |
| BR9509925A (pt) | 1997-09-30 |
| KR987000088A (ko) | 1998-03-30 |
| DE69535366D1 (de) | 2007-02-22 |
| NZ297006A (en) | 2001-03-30 |
| US5968910A (en) | 1999-10-19 |
| WO1996016675A3 (en) | 1996-08-29 |
| HUT77573A (hu) | 1998-06-29 |
| HU223548B1 (hu) | 2004-09-28 |
| CA2204652A1 (en) | 1996-06-06 |
| EP0794793A1 (en) | 1997-09-17 |
| JPH10500996A (ja) | 1998-01-27 |
| DE69535366T2 (de) | 2007-10-11 |
| CN1167442A (zh) | 1997-12-10 |
| ZA9510108B (en) | 1996-06-06 |
| IL115944A0 (en) | 1996-05-14 |
| CN1104909C (zh) | 2003-04-09 |
| KR100403545B1 (ko) | 2004-05-27 |
| IL115944A (en) | 2001-10-31 |
| AU717025B2 (en) | 2000-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2114487B1 (es) | Mezcla estabilizante sinergistica. | |
| WO1995033464A3 (en) | Retroviral protease inhibitor combinations | |
| SE9604793D0 (sv) | New polymorphs | |
| NZ324603A (en) | Treatment of the CNS effects of HIV with VX-478, alone or in combination with AZT or 3TC | |
| MY131388A (en) | Inhibitors of hiv protease useful for the treatment of aids. | |
| NO305478B1 (no) | Hydroksyetylaminosulfonamider som retrovirale proteasehemmere | |
| LV12719A (lv) | Benzoxazinones as inhibitors of hiv reverse transcriptase | |
| NO932620L (no) | Amindiol-proteaseinhibitorer | |
| AU688952B2 (en) | Thrombin inhibitors | |
| HK1016088A1 (en) | Use of ritonavir (abt-538) for improving the pharmacokinetics of drugs metabolized by cytochrome p450 in a method of treating aids | |
| AU9125191A (en) | Retroviral protease inhibitors | |
| DE69709727D1 (de) | Parazinon thrombin inhibitoren | |
| ATE183294T1 (de) | Abdichtung | |
| MY142948A (en) | Benzophenones as inhibitors of reverse transcriptase | |
| MX9704024A (es) | Composicion y metodo para la prevencion y el tratamiento de infeccion con vih-1. | |
| AU8074894A (en) | Hiv protease inhibitors and intermediates | |
| ZA991029B (en) | Composition and methods for treatment of hiv infections. | |
| EP0858262A4 (en) | THROMBIN INHIBITORS | |
| BG105953A (en) | Method for treating copd | |
| EE9700165A (et) | Ühendite kombinatsioon, meetod ja farmatseutiline kompositsioon HIV proteaasi ja HIV pöördtranskriptaasi inhibeerimiseks ning HIV infektsiooni vältimiseks või raviks, või AIDS-i või ARC raviks | |
| IL132477A0 (en) | Methods of screening compounds useful for prevention of infection or pathogenicity | |
| AU6739396A (en) | Method for combatting fish mycoses and one-celled ectoparasites | |
| MX9603898A (es) | Bioensayo para inhibidores de transcriptasa inversa. | |
| NL193531B (nl) | Ontruimingsstelsel voor een buitengaats werkeiland of dergelijke. | |
| AU5417696A (en) | Substituted tetronic acids useful for treating hiv and other retroviruses |